1000166-82-4 Usage
Uses
Used in Pharmaceutical Research:
Pentylhydrazone is utilized as a chemical intermediate in the synthesis of potential drug candidates, particularly for its potential anticancer and antiviral properties. It serves as a valuable component in the development of novel therapeutic agents.
Used in Anticancer Applications:
In the field of oncology, pentylhydrazone is studied for its potential as an anticancer agent, where it may contribute to the inhibition of tumor growth and the disruption of cancer cell functions, offering a new avenue for cancer treatment.
Used in Antiviral Applications:
Pentylhydrazone is also being investigated for its antiviral capabilities, which could lead to the creation of new antiviral medications, particularly important in the face of emerging viral threats.
Used in Enzyme Inhibition Studies:
As a chemical tool, pentylhydrazone is used to inhibit certain enzymes, providing researchers with a means to study the effects of enzyme inhibition on biological systems and potentially leading to treatments for various diseases.
Used in Purine Receptor Research:
Pentylhydrazone aids in the study of purine receptors and their biological functions, which is crucial for understanding the complex roles these receptors play in cellular processes and could uncover new targets for therapeutic intervention.
Check Digit Verification of cas no
The CAS Registry Mumber 1000166-82-4 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,0,0,0,1,6 and 6 respectively; the second part has 2 digits, 8 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 1000166-82:
(9*1)+(8*0)+(7*0)+(6*0)+(5*1)+(4*6)+(3*6)+(2*8)+(1*2)=74
74 % 10 = 4
So 1000166-82-4 is a valid CAS Registry Number.
1000166-82-4Relevant academic research and scientific papers
PURINONE DERIVATIVES AS HM74A AGONISTS
-
Page/Page column 31-32, (2008/06/13)
The present invention relates to purinone derivatives which are agonists of the HM74a receptor. Further provided are compositions and methods of using the compounds herein, and their pharmaceutically acceptable salts for the treatment of disease.
